Evaluation of Intervention Measures on Controlling the Dissemination of Nontyphoidal Salmonella Disease in Mukuru Informal Settlement, Nairobi County, Kenya.
DOI:
https://doi.org/10.14738/bjhmr.101.14073Keywords:
Nontyphoidal Salmonella, antimicrobials, intervention, antimicrobial resistance, MukuruAbstract
Nontyphoidal Salmonella is the most common bacterial pathogen causing gastrointestinal infection worldwide. Data is limited on the effectiveness of the intervention measures put in place to help control the dissemination of nontyphoidal Salmonella disease on Mukuru informal settlement in Nairobi County, Kenya. The aim of the study was to determine the effectiveness of the intervention measures put in place to prevent and control the dissemination of nontyphoidal Salmonella disease in Mukuru informal settlement in Nairobi County, Kenya. A cross-sectional study was conducted in patients aged 0-5 years. Nontyphoidal Salmonella (NTS) bacteria was cultured from blood and stool collected from the recruited children who reported at three health facilities with symptoms of diarrhea, fever or vomiting and antimicrobial susceptibility testing of the recovered NTS isolates from the stool and blood samples was performed. A questionnaire was administered to obtain relevant demographic, socio-economic and healthcare utilization information. Fisher’s test was conducted to determine the difference in the susceptibility patterns between the isolated NTS. Out of 191 collected samples, 3 were found to be positive for Salmonella Typhimurium and Salmonella Enteritidis. Both S. Typhimurium and S. Enteritidis isolates were resistant to gentamycin. Salmonella Typhimurium was found also to be resistant to tetracycline drug. Significant differences existed between some of the drugs susceptibility patterns (p= 0.0048). There are still AMR strains circulating in Mukuru informal settlement. There is still need for the Kenyan government to strengthen knowledge and understanding of AMR through supporting surveillance and research.
References
Chen HM, Wang Y, Su LH, Chiu CH. Nontyphoid Salmonella Infection: Microbiology, Clinical Features, and Antimicrobial Therapy. Pediatr Neonatol. 2013 Jun;54(3):147–52.
Kariuki S, Mbae C, Van Puyvelde S, Onsare R, Kavai S, Wairimu C, et al. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya. Senok A, editor. PLoS Negl Trop Dis. 2020 Aug 3;14(8):e0008440.
Marchello CS, Dale AP, Pisharody S, Rubach MP, Crump JA. A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01974-19.
Xu H, Zhang W, Zhang K, Zhang Y, Wang Z, Zhang W, et al. Characterization of Salmonella serotypes prevalent in asymptomatic people and patients. BMC Infect Dis. 2021 Dec;21(1):632.
James J. Gilchrist, Calman A. MacLennan. Invasive Nontyphoidal Salmonella Disease in Africa.
Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC Med. 2020 Dec;18(1):212.
Stanaway JD. The global burden of non-typhoidal Salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. :1312–24.
Bashar S, Das A, Erdem S, Hafeez W, Ismail R. Severe Gastroenteritis From Giardia lamblia and Salmonella Saintpaul Co-Infection Causing Acute Renal Failure. Cureus [Internet]. 2022 May 24 [cited 2022 Jul 25]; Available from: https://www.cureus.com/articles/97708-severe-gastroenteritis-from-giardia-lamblia-and-salmonella-saintpaul-co-infection-causing-acute-renal-failure
Marchello CS, Birkhold M, Crump JA, Martin LB, Ansah MO, Breghi G, et al. Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis. Lancet Infect Dis. 2022 May;22(5):692–705.
Ngogo FA, Joachim A, Abade AM, Rumisha SF, Mizinduko MM, Majigo MV. Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania. BMC Infect Dis. 2020 Dec;20(1):135.
Ranjalkar J, Chandy S. India’s National Action Plan for antimicrobial resistance – An overview of the context, status, and way ahead. J Fam Med Prim Care. 2019;8(6):1828.
Kariuki S, Wairimu C, Mbae C. Antimicrobial Resistance in Endemic Enteric Infections in Kenya and the Region, and Efforts Toward Addressing the Challenges. J Infect Dis. 2021 Dec 20;224(Supplement_7):S883–9.
WHO. World Health Organization: NATIONAL ACTION PLAN ON PREVENTION AND CONTAINMENT OF ANTIMICROBIAL RESISTANCE, 2017 -2022. 2017 Jun; Available from: https://www.afro.who.int/publications/national-action-plan-prevention-and-containment-antimicrobial-resistance-2017-2022
Mekuria LA, de Wit TF, Spieker N, Koech R, Nyarango R, Ndwiga S, et al. Analyzing data from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in primary care in urban Kenya: A mixed-methods study. Rutebemberwa E, editor. PLOS ONE. 2019 Sep 26;14(9):e0222651.
Othieno JO, Njagi O, Azegele A. Opportunities and challenges in antimicrobial resistance behavior change communication. One Health. 2020 Dec;11:100171.
Kariuki S, Onsare RS. Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya. Clin Infect Dis. 2015 Nov 1;61(suppl 4):S317–24.
Feasey NA, Masesa C, Jassi C, Faragher EB, Mallewa J, Mallewa M, et al. Three Epidemics of Invasive Multidrug-Resistant Salmonella Bloodstream Infection in Blantyre, Malawi, 1998–2014. Clin Infect Dis. 2015 Nov 1;61(suppl 4):S363–71.
Bachou H, Tylleskär T, Kaddu-Mulindwa DH, Tumwine JK. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda. BMC Infect Dis. 2006 Dec;6(1):160.
Vandenberg O, Nyarukweba DZ, Ndeba PM, Hendriksen RS, Barzilay EJ, Schirvel C, et al. Microbiologic and Clinical Features of Salmonella Species Isolated From Bacteremic Children in Eastern Democratic Republic of Congo. Pediatr Infect Dis J. 2010 Jun;29(6):504–10.
Koolman L, Prakash R, Diness Y, Msefula C, Nyirenda TS, Olgemoeller F, et al. Case-control investigation of invasive Salmonella disease in Africa - comparison of human, animal and household environmental isolates find no evidence of environmental or animal reservoirs of invasive clades/strains [Internet]. Infectious Diseases (except HIV/AIDS); 2022 Feb [cited 2022 Jul 25]. Available from: http://medrxiv.org/lookup/doi/10.1101/2022.01.31.22270114
Kariuki S, Mbae C, Onsare R, Kavai SM, Wairimu C, Ngetich R, et al. Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings. Clin Infect Dis. 2019 Feb 15;68(Supplement_1):S10–5.
Piccini G, Montomoli E. Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development. Hum Vaccines Immunother. 2020 Sep 1;16(9):2056–71.
Mbae C, Mwangi M, Gitau N, Irungu T, Muendo F, Wakio Z, et al. Factors associated with occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya. BMC Infect Dis. 2020 Dec;20(1):422.
KNBS. Kenya National Bureau of Statistics: The 2009 Kenya Population and Housing Census. 2010 Aug;VOLUME IC:532.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Schola K. Peter Kamwethya, Joshua M. Mutiso, Samuel Kariuki
This work is licensed under a Creative Commons Attribution 4.0 International License.
